Leukocyte Depletion of Autologous Whole Blood: impact on perioperative infection rate and length of hospital stay for hip arthroplasty patients

ISRCTN ISRCTN99578441
DOI https://doi.org/10.1186/ISRCTN99578441
ClinicalTrials.gov (NCT) NCT00176124
Protocol serial number N/A
Sponsor University of Heidelberg (Germany)
Funders Auguste Schädler Stiftung, Dannstadt (Germany), Fresenius Medical Care AG, Bad Homburg (Germany), Faculty of Clinical Medicine Mannheim, University of Heidelberg (Germany)
Submission date
29/09/2003
Registration date
30/09/2003
Last edited
16/12/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Thomas Frietsch
Scientific

Department of Anesthesiology and Critical Care Medicine
Faculty of Clinical Medicine Mannheim
Theodor-Kutzer-Ufer 1-3
Mannheim
67167
Germany

Phone +49 (0)621 383 2415
Email thomas.frietsch@urz.uni-heidelberg.de

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study acronymLDAWB2001
Study objectivesAdded as of 16/12/2008:
Leukocyte depletion of autologous whole blood prior to storage does not reduce infection rate (wound, urinary tract, other), use of antibiotic treatment and length of hospital stay but may increase retransfusion perioperatively during hip arthroplasty and allogenic transfusion rate.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedArthrosis of the hip
InterventionAutologous blood donation, storage either as leukocyte depleted or undepleted whole blood, retransfusion perioperatively during hip arthroplasty, comparison of infection rate (wound, urinary tract, other), use of antibiotic treatment and length of hospital stay
Intervention typeOther
Primary outcome measure(s)

Added as of 16/12/2008:
Comparison of infection rate (wound, urinary tract, other), use of antibiotic treatment and length of hospital stay, measured at 90 days

Key secondary outcome measure(s)

Added as of 16/12/2008:
Blood loss and transfusion rate, measured at 90 days

Completion date30/04/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target sample size at registration1089
Key inclusion criteriaHip arthroplasty patients

Added as of 16/12/2008:
1. American Society of Anaesthesiologists (ASA) grade I - III
2. Aged 18 - 85 years
3. Body weight 50 - 125 kg
4. If female, with either a history of an accepted method of anticonception for at least 3 months prior and 1 month following the termination of the study or climacteric or with a negative beta-human chorionic gonadotropin (B-HCG) test in urine or serum
5. Pre-operative blood donation of at least 2 units (450 ml whole blood)
6. Pre-operative haemoglobin level greater than 10 mg/dl
7. Able and willing to sign informed consent
Key exclusion criteriaAdded 16/12/2008:
1. Subjects with a contraindication for pre-operative blood donation (PAD)
2. Systemic infection
3. Acute bacterial or viral diseases
4. Anaemia (haemogoblin [Hb] greater than 11 g/dL)
5. Myocardial infarction within the past 6 months
6. Unstable angina pectoris
7. Vascular stenosis (i.e. of the coronary or internal carotid arteries)
8. Haemodynamic relevant valvular stenosis
9. Heart failure greater than New York Heart Association (NYHA) II
10. History of strokes or transient ischaemic attack (TIA)
11. Steroid therapy
12. Immune deficiency
13. Haematological or endocrinological disease
14. Coagulopathy
15. History of organ transplantation
16. Simultaneous participation in a second study
17. Pregnancy
18. Membership at Jehovah's Witnesses
19. Intended use of a cell saver
Date of first enrolment01/04/2002
Date of final enrolment30/04/2005

Locations

Countries of recruitment

  • Germany

Study participating centre

Department of Anesthesiology and Critical Care Medicine
Mannheim
67167
Germany

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2008 Yes No